Bepotastine
- Level
- Commodity
- Parent
- 51313200
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51313203This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HYD2U48IAS. European Medicines Agency schedules Bepotastine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05778MIG. Bepotastine generally arises in the molecular formula C21H25CLN2O3. The term BEPOTASTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 no. 2 1999, list 40.) Most nations schedule bepotastine under HS 29333999 and SITC 51574. As of Q4 2014, BEPOTASTINE remains the US FDA Preferred Term for this commodity. Bepotastine bears US NLM identifiers UMLS ID C2698371 and NCI Concept Code C77431. SMILES: C1CN(CCC1O[C@@H](C2=CC=C(C=C2)Cl)C3=CC=CC=N3)CCCC(=O)O.
Same parent
Under 51313200 · 20Activities that produce or sell this
KBLI · 9Inherited from family 51310000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.